ISSCR Annual Meeting Publication

If you missed the 2003 or 2004 ISSCR Annual Meetings, you can still get access to the high-quality scientific programs .

Order your copy of the 2nd ISSCR Annual Meeting Final Program/Abstracts Volume, including the abstracts of all presented papers and posters, and the 1st ISSCR Annual Meeting Final Program/Abstracts Volume. Both programs are available as printable/searchable PDFs.

2nd ISSCR Annual Meeting Final Program/Abstracts Volume
Abstracts of all papers presented at the 2nd Annual Meeting
June 10-13, 2004 - Boston, Mass., U.S.A.
Printable/searchable PDF file (211 pages, 3,394 KB)
Read highlights.

1st ISSCR Annual Meeting Final Program/Abstracts Volume
Abstracts of all papers presented at the 1st Annual Meeting
June 8-10, 2003 - Washington, D.C., U.S.A.
Printable/searchable PDF file (24 pages, 1,887 KB)
Read highlights.

Order the Final Programs/Abstract Volumes today.

1st ISSCR Annual Meeting Audiotape
June 8-10, 2003 - Washington, D.C., U.S.A.
Download the order form for more details.

2nd ISSCR Annual Meeting Final Program/Abstracts Volume Highlights:

Presidential Symposium
Chair: Leonard I. Zon, ISSCR President
Ronald D. McKay, National Institutes of Health, NINDS, Laboratory of Molecular Biology, Bethesda, MD
Davor Solter, Max-Planck Institute of Immunobiology, Freiburg, Germany
David J. Anderson, California Institute of Technology, Pasadena, CA
Laurie S. Zoloth, Northwestern University, Feinberg School of Medicine, Chicago, IL
Hans C. Clevers, Hubrecht Laboratory, Netherlands Institute for Developmental Biology of the Royal Netherlands Academy of Arts and Sciences, Utrecht, The Netherlands

Plenary Sessions:
Locating and Defining Stem Cell Niches
Jeffrey Gordon, Washington University School of Medicine,
Department of Molecular Biology and Pharmacology, St. Louis, MO
David T. Scadden, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Kateri Ann Moore, Princeton University, Department of Molecular Biology, Princeton, NJ
Stuart Orkin, Dana-Farber Cancer Institute and Children's Hospital, Harvard Medical School, and Howard Hughes Medical Institute, Boston, MA

Stem Cell Regulators
Elaine Fuchs, The Rockefeller University, Howard Hughes Medical Institute andLaboratory of Mammalian Cell Biology and Development, New York, NY
James Sherley, Massachusetts Institite of Technology, Biological Engineering Division, Cambridge, MA
Irving L. Weissman, Stanford University School of Medicine, Department of Pathology, Stanford, CA
Michael Rudnicki, Ottawa Health Research Institute, Molecular Medicine Program, Ottawa, ON, Canada

Embryonic Stem Cells
Douglas A. Melton, Harvard University, Howard Hughes Medical Institute and Department of Cellular and Molecular Biology, Cambridge, MA
Nissim Benvenisty, Hebrew University, Jerusalem, Israel
Alan Trounson, Monash University, Institute of Reproduction and Development, Melbourne, VIC Australia
Shin-Ichi Nishikawa, RIKEN, Center for Developmental Biology, Kobe, Japan

Tissue Stem Cells
George Q. Daley, Children’s Hospital Boston, Boston, MA
Michael F. Clarke, University of Michigan, School of Medicine, Ann Arbor, MI
Annarosa Leri, New York Medical College, Cardiovascular Research Institute, Department of Medicine, Valhalla, NY
Hiromitsu Nakauchi, University of Tokyo, Center for Experimental Medicine, Institute of Medical Science, Tokyo, Japan
Pamela G. Robey, National Institutes of Health, Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD
Jonas Frisen, Karolinska Institute, Stockholm, Sweden

 Concurrent Sessions
Stem Cell Genomics
Ihor Lemischka, Princeton University, Department of Molecular Biology, Princeton, NJ
Gretchen Darlington, Baylor College of Medicine, Houston, TX
Natalia B. Ivanova, Princeton University, Princeton, NJ
Berthold Gottgens, Cambridge University, Cambridge, United Kingdom
Hans Snoeck, Mount Sinai School of Medicine, New York, NY

Germ Stem Cells
Allan Spradling, Carnegie Institute, Baltimore, MD
Woo Suk Hwang, Seoul National University, Department of Theriogenology and Biotechnology, Seoul, South Korea
Haifan Lin, Duke University Medical School, Durham, NC
Robert Blelloch, Whitehead Institute of Biomedical Research, Cambridge, MA
Ting Xie, Stowers Institute for Medical Research, Kansas City, MO

 Embryonic Development of Stem Cells
Leonard I. Zon, Children’s Hospital Boston, Division of Hematology/Oncology, Department of Medicine, Boston, MA
Kevin Eggan, Harvard University, Department of Molecular and Cellular Biology, Cambridge, MA
Roger Patient, University of Nottingham Institute of Genetics, Nottingham, United Kingdom
Margaret Baron, Mount Sinai School of Medicine, New York, NY
Tara Huber, Mount Sinai School of Medicine, Department of Gene Therapy and Molecular Medicine, New York, NY

The Ethics of Stem Cell Research
Laurie S. Zoloth, Northwestern University, Feinberg School of Medicine, Chicago, IL
Adrienne Asch, Wellesley College, Wellesley, MA
Louis M. Guenin, Harvard Medical School, Boston, MA
Mark Greene, Johns Hopkins University, Phoebe R. Berman Bioethics Institute, Baltimore, MD
John Robertson, University of Texas Law School, Austin, TX

 Stem Cell Self-Renewal I
Sean Morrison, University of Michigan, Howard Hughes Medical Institute and Department of Internal Medicine, Ann Arbor, MI
Ira B. Black, UMDNJ-Robert Wood Johnson Medical School, Department of Neuroscience and Cell Biology, Piscataway, NJ
Linheng Li, Stowers Institute for Medical Research, Kansas City, MO
Hiromi Iwasaki, Dana-Farber Cancer Institute, Boston, MA
Yanhong Shi, Beckman Research Institute at City of Hope National Medical Center, Duarte, CA

Stem Cell Self-Renewal II
Fred H. Gage, The Salk Institute for Biological Studies, Laboratory of Genetics, La Jolla, CA
Bruno Peault, INSERM U506, Hospital Paul Bush, Villejuif, France
Emmanuelle Passegue, Stanford University, Stanford, CA
Keisuke Ito, Keio University School of Medicine, Tokyo, Japan
Alexey Tomilin, Max-Planck Institute of Immunobiology, Freiburg, Germany

Stem Cell Differentiation I
Melissa Little, Institute for Molecular Bioscience, St. Lucia, QLD Australia
Paul J. Simmons, Peter MacCallum Cancer Centre, Melbourne, VIC Australia
Nancy Joseph, University of Michigan, Ann Arbor, MI
Magdalena Gotz, Max-Planck Institute of Neurobiology, Martinsried/Munich, Germany
Paul Sammak, University of Pittsburgh, Department of Obstetrics/Gynecology and Reproductive Sciences, Pittsburgh, PA

Stem Cell Differentiation II
Perry Bartlett, University of Queensland, St. Lucia, QLD Australia
Philip Crosier, University of Auckland School of Medical Sciences, Auckland, New Zealand
Linzhao Cheng, Johns Hopkins University, Baltimore, MD
Benjamin Reubinoff, The Hadassah Embryonic Stem Cell Research Center, Jerusalem, Israel
Victor Bartsevich, Sangamo BioSciences, Inc., Richmond, CA

Embryonic Stem Cells
Shinya Yamanaka, Nara Institute of Science and Technology, Nara, Japan
Kyunghee Choi, Washington University School of Medicine, Department of Pathology and Immunology, St. Louis, MO
Mickie Bhatia, Robarts Research Institute, London, ON, Canada
Thomas P. Zwaka, National Primate Research Center, Madison, WI
Shulamit Levenberg, Massachusetts Institute of Technology, Cambridge, MA 

Regulatory Challenges and Funding Opportunities in Stem Cell Research
James Battey, National Institutes of Health, Bethesda, MD
Joyce Frey-Vasconcells, U.S. Food and Drug Administration, Rockville, MD
Robert Goldstein, Juvenile Diabetes Research Foundation, New York, New York 

Tissue Engineering and Clinical Use of Stem Cells
Anthony Atala, Wake Forest University School of Medicine, Winston-Salem, NC
Ren-Ke Li, Toronto General Hospital, Division of Cardiovascular Surgery, Toronto, ON Canada
Joaquin Cortiella, University of Texas Medical Branch, Galveston, TX
Robert Passier, Hubrecht Laboratory, Upsalalaan, Utrecht, The Netherlands
Jonathan Jones, University Miguel Hernandez, Institute of Bioengineering, San Juan, Alicante, Spain

Tissue Stem Cells I
Markus Grompe, Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR
Louis M. Kunkel, Children’s Hospital Boston, Department of Genetics, Boston, MA
Yuval Dor, Harvard University, Cambridge, MA
John Stingl, StemCell Technologies, Vancouver, BC, Canada
Hanna Mikkola, Dana-Farber Cancer Institute, Boston, MA  

Tissue Stem Cells II
Helen Blau, Stanford University School of Medicine, Baxter Laboratory in Genetic Pharmacology, Department of Microbiology and Immunology, Stanford, CA
Margaret Goodell, Baylor College of Medicine, Center for Cell and Gene Therapy, Houston, TX
Alan Davidson, Children’s Hospital Boston and Dana-Farber Cancer Institute, Boston, MA
Daniel Blashki, Peter MacCallum Cancer Centre, Melbourne, VIC Australia
Kiarash Khosrotehrani, Tufts-New England Medical Center, Division of Genetics, Boston, MA 

Industry and Medicine
Claudio Bordignon, Science Institute San Raffaele, Milano, Italy
Fyodor Urnov, Sangamo BioSciences, Inc., Richmond, CA
Nobuko Uchida, StemCells, Inc., Palo Alto, CA
Oren Caspi, Cardiovascular Research Laboratory, The Technion, Haifa, Israel

Back to top

1st ISSCR Annual Meeting Final Program/Abstracts Volume Highlights:

Tissue Stem Cells
Moderator: Douglas A. Melton, Harvard University
Douglas A. Melton, Harvard University; Ronald D. McKay, National Institutes of Health
Sally Temple, Albany Medical College
Gordon M. Keller, Mount Sinai Hospital
Norman N. Iscove, The Ontario Cancer Institute
Margaret A. Goodell, Baylor College of Medicine

Stem Cell Genomics
Moderator: Douglas A. Melton, Harvard University
Ihor R. Lemischka, Princeton University
Alexey V. Terskikh, Burnham Institute
Miguel Ramalho-Santos, Harvard University
Ralph Brandenberger, Geron Corporation

Primordial Germ Cells — Their Special Status as Stem Cells
Moderator: Davor Solter, Max-Planck Institute of Immunobiology
Davor Solter, Max-Planck Institute of Immunobiology
Azim Surani, University of Cambridge
Ruth Lehmann, New York University
Daniel D. Kalderon, Columbia University
Amander Clark, University of California at San Francisco

Stem Cell Plasticity
Moderator: George Stamatoyannopoulos, University of Washington
Diane S. Krause, Yale University
Martin Raff, University College London
Arturo Alvarez-Buylla, University of California at San Francisco
Giulio Cossu, Stem Cell Research Institute, Rome
Tannishtha Reya, Duke University Medical Center

Clinical Use of Stem Cells
Moderator: W. French Anderson, University of Southern California
Donald B. Kohn, Children’s Hospital in Los Angeles
Olle Lindvall, University of Lund
Judith A. Shizuru, Stanford University
George Q. Daley, MIT/Whitehead Institute

Organ Stem Cells
Moderator: Irving L. Weissman, Stanford University
Sean J. Morrison, University of Michigan
Darwin J. Prockop, Tulane University
Paul J. Simmons, The Peter MacCallum Cancer Institute
David Traver, Children’s Hospital Boston

Back to top

 Updated: September 21, 2004